There was no statistically significant difference on the leptin level by subgroup analysis in gender, presence of diabetes and hypertension, and use of ACE inhibitor, ARB, β-blockers, CCB, statin, or fibrate. This evidence concerns the gene LEP and hypertensive disorder.